CELEBREX 200 MG
CELECOXIB : 200 MG · DIN 02239942 · BGP PHARMA ULC
Health Canada status: MARKETED
What is CELEBREX?
CELEBREX 200 MG contains CELECOXIB : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02239942, held by BGP PHARMA ULC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 26-Sep-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CELEBREX used for?
CELEBREX (celecoxib capsules) is indicated for relief of symptoms associated with: Osteoarthritis, Adult Rheumatoid Arthritis, and Ankylosing Spondylitis. CELEBREX is also indicated for the short-term (<= 7 days) management of moderate to severe acute pain in adults in conditions such as the following: Musculoskeletal and/or soft tissue trauma including sprains, Postoperative orthopaedic, and Pain following dental extraction.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02239942 |
|---|---|
| Brand name | CELEBREX |
| Generic / active ingredient | CELECOXIB : 200 MG |
| Manufacturer | BGP PHARMA ULC |
| Strength | 200 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | M01AH01 CELECOXIB |
| AHFS class | 28:08.04.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 26-Sep-2023 |
How is it administered?
Osteoarthritis/Ankylosing Spondylitis: 200 mg/day. Rheumatoid Arthritis: 100-200 mg twice daily. Acute Pain: 400 mg initially, then 200 mg daily (max 7 days). Use lowest effective dose for shortest duration.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
null
How is it supplied?
Bottles of 100, and in blister strips of 3 capsules
Contraindications
CABG surgery peri-operative setting; third trimester of pregnancy; breastfeeding; severe heart failure; hypersensitivity to celecoxib or sulfonamides; history of asthma/allergic reactions to ASA/NSAIDs; active GI ulcer/bleeding; cerebrovascular bleeding; IBD; severe liver/renal impairment; hyperkalemia; age < 18.
Warnings and precautions
Increased risk of serious cardiovascular thrombotic events (MI, stroke), especially at doses > 200 mg/day. Risk of serious GI toxicity (bleeding, ulceration). Can cause hypertension and fluid retention.
What can be used instead?
Other Canadian products sharing ATC code M01AH01 CELECOXIB. 30 of 69 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-CELECOXIB | 100 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02437570 |
| AG-CELECOXIB | 200 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02437589 |
| APO-CELECOXIB | 100 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02418932 |
| APO-CELECOXIB | 200 MG | CAPSULE | APOTEX INC | MARKETED | DIN 02418940 |
| AURO-CELECOXIB | 100 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02445670 |
| AURO-CELECOXIB | 200 MG | CAPSULE | AURO PHARMA INC | MARKETED | DIN 02445689 |
| BIO-CELECOXIB | 100 MG | CAPSULE | BIOMED PHARMA | MARKETED | DIN 02426382 |
| BIO-CELECOXIB | 200 MG | CAPSULE | BIOMED PHARMA | MARKETED | DIN 02426390 |
| CELEBREX | 100 MG | CAPSULE | BGP PHARMA ULC | MARKETED | DIN 02239941 |
| CELECOXIB | 100 MG | CAPSULE | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02429675 |
Who else supplies CELECOXIB worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CELECOXIB appears in 372 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.